Stay updated on BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Sign up to get notified when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.

Latest updates to the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page
- Check3 days agoChange DetectedThe BELINDA study record is now available, with details on its design, eligibility criteria, participating locations, outcome measures, and supporting documents.SummaryDifference93%

- Check10 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error page, with its footer revision identifier updated from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA notice about NIH’s terminology transition was added above the 403 error page. The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe footer now displays revision v3.7.1 instead of v3.7.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedCore elements such as investigator sites and locations and several essential study documents have been removed. The update also eliminates IPD sharing information, affecting access to important materials and data-sharing plans related to the trial.SummaryDifference19%

- Check59 days agoChange DetectedThe page now shows Revision: v3.7.0, replacing the previous v3.6.6 tag, indicating a site version update rather than a change to the study details.SummaryDifference0.0%

Stay in the know with updates to BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Enter your email address, and we'll notify you when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.